Role of Psychosocial Variables on Chemotherapy-Induced Nausea and Vomiting and Health-Related Quality of Life among Cancer Patients: A European Study

Psychotherapy and Psychosomatics

Volumn 84, Issue 6, 2015, Pages 339-347

  Grassi, Luigi ^a   Berardi, Maria Alejandra ^b   Ruffilli, Federica ^b   Meggiolaro, Elena ^b   Andritsch, Elisabeth ^d   Sirgo, Agustina ^e   Caruso, Rosangela ^a   Juan Linares, Eva ^f   Bellé, Marta ^c   Massarenti, Sara ^a   Nanni, Maria Giulia ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^c AULSS 2 Marca Trevigiana   (Italy)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Chemotherapy induced nausea and vomiting; Coping; Emotional distress; Hopelessness

Indexed keywords

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; AUSTRIA; CANCER PATIENT; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COPING BEHAVIOR; DISTRESS THERMOMETER; DOCTOR PATIENT RELATION; EMOTIONAL STRESS; FEMALE; FUNCTIONAL LIVING INDEX FOR EMESIS; HELPLESSNESS; HOPELESSNESS; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALADJUSTMENT; MALE; MINI MENTAL ADJUSTMENT TO CANCER SCALE; PATIENT SATISFACTION; PATIENT SATISFACTION WITH DOCTOR QUESTIONNAIRE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SPAIN; THERMOMETER; VOMITING; ADAPTIVE BEHAVIOR; COMPLICATION; EUROPE; MENTAL STRESS; MIDDLE AGED; NAUSEA; NEOPLASMS; PSYCHOLOGIC TEST; PSYCHOLOGY; YOUNG ADULT;

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; VOMITING; YOUNG ADULT;

EID: 84942274978     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000431256     Document Type: Article

References (56)

1. Jordan K, Sippel C, Schmoll HJ: Guidelines for antiemetic treatment of chemotherapyinduced nausea and vomiting: past, present, and future recommendations. Oncologist 2007; 12: 1143-1150.
2. Feyer P, Jordan K: Update and new trends in antiemetic therapy: the continuing need for novel therapies. Ann Oncol 2011; 22: 30-38.
3. Jordan K, Gralla R, Jahn F, Molassiotis A: International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice. Eur J Pharmacol 2014; 722: 197-202.
4. Hesketh PJ: Chemotherapy-induced nausea and vomiting. N Engl J Med 2008; 358: 2482-2494.
5. Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJ, Gundy CM, Aaronson NK: Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer 2012; 20: 107-117.
6. Molassiotis A, Stricker CT, Eaby B, Velders L, Coventry PA: Understanding the concept of chemotherapy-related nausea: the patient experience. Eur J Cancer Care (Engl) 2008; 17: 444-453.
7. Liau CT, Chu NM, Liu HE, Deuson R, Lien J, Chen JS: Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs patients' reported outcomes. Support Care Cancer 2005; 13: 277-286.
8. Ballatori E, Roila F, Ruggeri B, Betti M, Sarti S, Soru G, Cruciani G, Di Maio M, Andrea B, Deuson RR: The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Support Care Cancer 2007; 15: 179-185.
9. Fernández-Ortega P, Caloto MT, Chirveches E, Marquilles R, Francisco JS, Quesada A, Suárez C, Zorrilla I, Gómez J, Zabaleta P, Nocea G, Llombart-Cussac A: Chemotherapyinduced nausea and vomiting in clinical practice: impact on patients' quality of life. Support Care Cancer 2012; 20: 3141-3148.
10. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J: Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 2006; 24: 4472-4478.
11. Haiderali A, Menditto L, Good M, Teitelbaum A, Wegner J: Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US population. Support Care Cancer 2011; 19: 843-851.
12. Farrell C, Brearley SG, Pilling M, Molassiotis A: The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life. Support Care Cancer 2013; 21: 59-66.
13. Jacobsen PB, Andrykowski MA, Redd WH, Die-Trill M, Hakes TB, Kaufman RJ, Currie VE, Holland JC: Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer. Cancer 1988; 61: 379-385.
14. Montgomery GH, Bovbjerg DH: Expectations of chemotherapy-related nausea: emotional and experiential predictors. Ann Behav Med 2003; 25: 48-54.
15. Shih V, Wan HS, Chan A: Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide. Ann Pharmacother 2009; 43: 444-452.
16. Higgins SC, Montgomery GH, Bovbjerg DH: Distress before chemotherapy predicts delayed but not acute nausea. Support Care Cancer 2007; 15: 171-177.
17. Molassiotis A, Stamataki Z, Kontopantelis E: Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer 2013; 21: 2759-2767.
18. Pirri C, Katris P, Trotter J, Bayliss E, Bennett R, Drummond P: Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study. Support Care Cancer 2011; 19: 1549-1563.
19. Yap KY, Low XH, Chui WK, Chan A; Onco-Informatics Group: Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting. J Clin Psychopharmacol 2012; 32: 207-217.
20. Zook DJ, Yasko JM: Psychologic factors: their effect on nausea and vomiting experienced by clients receiving chemotherapy. Oncol Nurs Forum 1983; 10: 76-81.
21. Watson M, Meyer L, Thomson A, Osofsky S: Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer 1998; 34: 831-837.
22. Grassi L, Travado L, Gil F, Sabato S, Rossi E, Tomamichel M, Marmai L, Biancosino B, Nanni MG; SEPOS Group: Hopelessness and related variables among cancer patients in the Southern European Psycho-Oncology Study (SEPOS). Psychosomatics 2010; 51: 201-207.
23. Price A, Goodwin L, Rayner L, Shaw E, Hansford P, Sykes N, Monroe B, Higginson I, Hotopf M, Lee W: Illness perceptions, adjustment to illness, and depression in a palliative care population. J Pain Symptom Manage 2012; 43: 819-832.
24. Kim Y, Morrow GR: Changes in family relationships affect the development of chemotherapy-related nausea symptoms. Support Care Cancer 2003; 11: 171-177.
25. Kim Y, Morrow GR: The effects of family support, anxiety, and post-treatment nausea on the development of anticipatory nausea: a latent growth model. J Pain Symptom Manage 2007; 34: 265-276.
26. Efficace F, Baccarani M, Rosti G, Cottone F, Castagnetti F, Breccia M, Alimena G, Iurlo A, Rossi AR, Pardini S, Gherlinzoni F, Salvucci M, Tiribelli M, Vignetti M, Mandelli F: Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study. Br J Cancer 2012; 107: 904-909.
27. Trevino KM, Fasciano K, Prigerson HG: Patient-oncologist alliance, psychosocial wellbeing, and treatment adherence among young adults with advanced cancer. J Clin Oncol 2013; 31: 1683-1689.
28. Salsman JM, Grunberg SM, Beaumont JL, Rogers M, Paul D, Clayman ML, Cella D: Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives. J Natl Compr Canc Netw 2012; 10: 149-157.
29. Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, Burke TA, Gu A, Roila F: Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manage 2014; 47: 839-848.
30. National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology. Guidelines for supportive care/distress management. Version 2. Jenkintown, NCCN, 2013. www.nccn.org.
31. Donovan KA, Grassi L, McGinty HL, Jacobsen PB: Validation of the Distress Thermometer worldwide: state of the science. Psychooncology 2014; 23: 241-250.
32. Grassi L, Johansen C, Annunziata MA, Capovilla E, Costantini A, Gritti P, Torta R, Bellani M; Italian Society of Psycho-Oncology Distress Thermometer Study Group: Screening for distress in cancer patients: a multicenter, nationwide study in Italy. Cancer 2013; 119: 1714-1721.
33. Watson M, Law M, dos Santos M, Greer S, Baruch J, Bliss J: The Mini-MAC: further development of the Mental Adjustment to Cancer scale. J Psychosoc Oncol 1994; 12: 33-46.
34. Grassi L, Buda P, Cavana L, Annunziata MA, Torta R, Varetto A: Styles of coping with cancer: the Italian version of the Mini-Mental Adjustment to Cancer (Mini-MAC) scale. Psychooncology 2005; 14: 115-124.
35. Loblaw DA, Bezjak A, Bunston T: Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction with Doctor Questionnaire. J Clin Oncol 1999; 17: 1931-1938.
36. Loblaw DA, Bezjak A, Singh PM, Gotowiec A, Joubert D, Mah K, Devins GM: Psychometric refinement of an outpatient, visit-specific satisfaction with doctor questionnaire. Psychooncology 2004; 13: 223-234.
37. Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT: Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1992; 1: 331-340.
38. Schipper H, Clinch J, McMurray A, Levitt M: Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984; 2: 472-483.
39. Martin AR, Pearson JD, Cai B, Elmer M, Horgan K, Lindley C: Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall. Support Care Cancer 2003; 11: 522-527.
40. Hesketh PJ, Kris MG, Grunberg SM, Beck T, Hainsworth JD, Harker G, Aapro MS, Gandara D, Lindley CM: Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997; 15: 103-109.
41. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D; ESMO/MASCC Guidelines Working Group: Guideline update for MASCC and ESMO in the prevention of chemotherapyand radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 2010; 21(suppl 5):v232-v234.
42. Grunberg SM, Warr D, Gralla RJ, Rapoport BL, Hesketh PJ, Jordan K, Espersen BT: Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity-state of the art. Support Care Cancer 2011; 19(suppl 1):S43-S47.
43. Arpawong TE, Richeimer SH, Weinstein F, Elghamrawy A, Milam JE: Posttraumatic growth, quality of life, and treatment symptoms among cancer chemotherapy outpatients. Health Psychol 2013; 32: 397-408.
44. Koller M, Heitmann K, Kussmann J, Lorenz W: Symptom reporting in cancer patients. II. Relations to social desirability, negative affect, and self-reported health behaviors. Cancer 1999; 86: 1609-1620.
45. Badger TA, Braden CJ, Mishel MH: Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer. Oncol Nurs Forum 2001; 28: 567-574.
46. Grassi L, Travado L, Moncayo Gil F, Sabato S, Rossi E; SEPOS Group: Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Disord 2004; 83: 243-248.
47. Wedding U, Koch A, Röhrig B, Pientka L, Sauer H, Höffken K, Maurer I: Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy. Acta Oncol 2008; 47: 56-62.
48. Roscoe JA, Bushunow P, Morrow GR, Hickok JT, Kuebler PJ, Jacobs A, Banerjee TK: Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer 2004; 101: 2701-2708.
49. Roscoe JA, Morrow GR, Aapro MS, Molassiotis A, Olver I: Anticipatory nausea and vomiting. Support Care Cancer 2011; 19: 1533-1538.
50. Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, Sakamoto M, Komatsu H, Ueda R, Wada M, Furukawa TA: Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: prevalence, associated factors, and impact on quality of life. Cancer Sci 2010; 101: 2596-2600.
51. Kamen C, Tejani MA, Chandwani K, Janelsins M, Peoples AR, Roscoe JA, Morrow GR: Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol 2014; 722: 172-179.
52. Grassi L, Rosti G: Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients with cancer. Psychother Psychosom 1996; 65: 246-252.
53. Grassi L, Malacarne P, Maestri A, Ramelli E: Depression, psychosocial variables and occurrence of life events among patients with cancer. J Affect Dis 1997; 44: 21-30.
54. Sirri L, Fava GA, Sonino N: The unifying concept of illness behavior. Psychother Psychosom 2013; 82: 74-81.
55. Tecuta L, Tomba E, Grandi S, Fava GA: Demoralization: a systematic review on its clinical characterization. Psychol Med 2015; 45: 673-691.
56. Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R: Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 2013; 21: 735-748.